Tyson Foods, Inc. TSN
59.28 USD +2.32 (+4.07%)
Nov 4, 2026, 1:03 PM EST
57.70 Day range 59.53
50.47 52-week range 68.75
- YTD
- +1.13%
- 1 year
- +13.91%
Analyst view
Consensus: hold
Hold
Price target (mean) 63.00 +6.3% upside
Now 59.28
- Target (low)
- 56.00
- Target (mean)
- 63.00
- Target (high)
- 75.00
Ratings (0m) 13 5 buy · 7 hold · 1 sell
- Strong buy3
- Buy2
- Hold7
- Sell0
- Strong sell1
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.59996 | 0.49 – 1.13 | 1.15 | -47.8% | 14.10B | +1.7% | 8 |
| Next quarter | 0.97403 | 0.89 – 1.17 | 0.97 | +0.4% | 14.27B | -0.3% | 6 |
| Current year | 3.55 | 3.32 – 4.11 | 4.12 | -13.7% | 56.20B | +3.2% | 10 |
| Next year | 3.86 | 3.33 – 4.99 | 3.55 | +8.6% | 55.44B | -1.3% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 7, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Sep 18, 2026 | JP Morgan | Upgrade | Neutral | Overweight |
| Sep 10, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Sep 4, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Sep 4, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 14, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 2, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Jul 2, 2026 | Bernstein | Maintained | Market Perform | Market Perform |
| Jun 18, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| May 5, 2026 | Stephens & Co. | Maintained | Equal-Weight | Equal-Weight |
| Apr 6, 2026 | Piper Sandler | Upgrade | Neutral | Overweight |
| Mar 26, 2026 | Mizuho | Initiated | Buy | Outperform |
| Mar 24, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Feb 3, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Feb 3, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Feb 3, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jan 8, 2026 | BMO Capital | Upgrade | Market Perform | Outperform |
| Dec 12, 2025 | Piper Sandler | Maintained | Neutral | Neutral |
| Nov 11, 2025 | BMO Capital | Maintained | Market Perform | Market Perform |
| Oct 8, 2025 | B of A Securities | Maintained | Neutral | Neutral |
| Jul 23, 2025 | Bernstein | Downgrade | Outperform | Market Perform |
| Jun 23, 2025 | Goldman Sachs | Initiated | — | Buy |
| May 6, 2025 | Stephens & Co. | Maintained | Equal-Weight | Equal-Weight |
| May 6, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Apr 15, 2025 | Citigroup | Maintained | Neutral | Neutral |
| Feb 4, 2025 | Stephens & Co. | Maintained | Equal-Weight | Equal-Weight |
| Feb 4, 2025 | Piper Sandler | Upgrade | Underweight | Neutral |
| Jan 21, 2025 | Barclays | Maintained | Overweight | Overweight |
| Jan 10, 2025 | UBS | Initiated | — | Neutral |
| Nov 13, 2024 | Piper Sandler | Maintained | Underweight | Underweight |
